Senior Consultant
National University Cancer Institute, Singapore
Professor Wee Joo Chng is a Yong Loo Lin Professor in Medical Oncology and Vice President (Biomedical Sciences Research) at the National University of Singapore, where he is also a Senior Principal Investigator of the Cancer Science Institute of Singapore. He is a Senior Consultant at the National University Cancer Institute, Singapore and concurrently serves as the Group Director of Research at the National University Health System and the inaugural Executive Director of the Singapore Translational Cancer Consortium.
A hematologist by training, Professor Chng is an esteemed researcher in the fields of genomics, therapeutics and hematologic malignancies, with a wealth of experience spanning clinical practice, administration, and leadership. He has produced highly translational research, including using global genomic techniques to understand drug resistance and improve disease prognosis in hematological malignancies — that has helped to personalise treatment and improve patient outcomes. His impactful research has won him numerous national and global accolades, including the International Myeloma Foundation’s Brian G.M. Durie Outstanding Achievement Award in 2020 — becoming the first in Asia to achieve this honour — and the National Medical Research Council’s National Outstanding Clinician Scientist Award in 2016.
Professor Chng is the chair of the Asian Myeloma Network and a member of various leading national and international professional committees, iincluding the American Society of Hematology and the International Myeloma Working Group, and a former president of the Singapore Society of Hematology. He regularly engages in clinical trials, has authored more than 350 publications in numerous reputable journals, and has delivered talks at many national and international conferences.
Disclosure information not submitted.
Saturday, September 20, 2025
08:00 - 08:50 East Coast USA Time